Finance

Beta
Lists
1530:HKG
3SBio Inc
HK$15.23
-2.87%
(-0.45) 1D
Jun 8, 4:09:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1530...
Open
HK$15.30
High
HK$15.55
Low
HK$14.96
Mkt. cap
38.66B
Avg. vol.
33.35M
Volume
29.98M
Dividend
1.64%
Quarterly dividend
HK$0.06
Ex-dividend date
Jul 22, 2024
P/E ratio
3.83
52-wk high
HK$36.80
52-wk low
HK$14.96
EPS
HK$3.98
Shares outstanding
2.54B
No. of employees
6K
Open
HK$15.30
High
HK$15.55
Low
HK$14.96
Mkt. cap
38.66B
Avg. vol.
33.35M
Volume
29.98M
Dividend
1.64%
Quarterly dividend
HK$0.06
Ex-dividend date
Jul 22, 2024
P/E ratio
3.83
52-wk high
HK$36.80
52-wk low
HK$14.96
EPS
HK$3.98
Shares outstanding
2.54B
No. of employees
6K
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to 1530 in the past 3 months
Strong Buy
Buy
6
Hold
1
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for 1530 in the last 3 months.
Highest
Current HK$15.23
HK$38.30 (+151.48%)
Average
HK$35.10 (+130.45%)
Lowest
HK$29.43 (+93.24%)
News stories
From sources across the web
About 3SBio Inc
CEO-
Employees6.11K
Founded1993
HeadquartersShenyang, Liaoning, China
SectorBiotechnology
Website3sbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.18B
2.18B
6.67B
6.67B
Cost of goods sold
319.84M
319.84M
354.38M
354.38M
Cost of revenue
319.84M
319.84M
354.38M
354.38M
Research and development expenses
273.76M
273.76M
486.42M
486.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
949.67M
949.67M
1.19B
1.19B
Operating expense
1.23B
1.23B
1.70B
1.70B
Total operating expenses
1.55B
1.55B
2.05B
2.05B
Operating income
626.02M
626.02M
4.62B
4.62B
Other non operating income
27.57M
27.57M
34.14M
34.14M
EBT including unusual items
810.85M
810.85M
4.56B
4.56B
EBT excluding unusual items
685.28M
685.28M
4.58B
4.58B
Income tax expense
116.56M
116.56M
709.43M
709.43M
Effective tax rate
14.38%
14.38%
15.55%
15.55%
Other operating expenses
8.45M
8.45M
20.37M
20.37M
Net income
679.10M
679.10M
3.56B
3.56B
Net profit margin
31.18%
31.18%
53.40%
53.40%
Earnings per share
-
-
-
-
Interest and investment income
41.97M
41.97M
109.92M
109.92M
Interest expense
-26.50M
-26.50M
-11.69M
-11.69M
Net interest expenses
15.47M
15.47M
98.23M
98.23M
Depreciation and amortization charges
-
-
-
-
EBITDA
736.91M
736.91M
4.76B
4.76B
Gain or loss from assets sale
2.82M
2.82M
3.07M
3.07M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer